BIOMAT Database Logo BIOMAT Database Logo

Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis. 2023

Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii, USA.

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074322 Antineoplastic Agents, Immunological Antineoplastic agents containing immunological agents (e.g. MAbs). These pharmacologic preparations inhibit or prevent the proliferation of NEOPLASMS. Antineoplastic MAbs,Antineoplastics, Monoclonal Antibodies,Antineoplastics, Monoclonal Antibody,MAbs, Antineoplastic,Monoclonal Antibodies, Antineoplastic,Antibodies Antineoplastics, Monoclonal,Antineoplastic Monoclonal Antibodies,Immunological Antineoplastic Agents,Monoclonal Antibodies Antineoplastics,Monoclonal Antibody Antineoplastics
D000082082 Immune Checkpoint Inhibitors Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies. CTLA-4 Inhibitor,CTLA-4 Inhibitors,Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitor,Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors,Immune Checkpoint Blockade,Immune Checkpoint Blockers,Immune Checkpoint Inhibition,Immune Checkpoint Inhibitor,PD-1 Inhibitor,PD-1 Inhibitors,PD-1-PD-L1 Blockade,PD-L1 Inhibitor,PD-L1 Inhibitors,Programmed Cell Death Protein 1 Inhibitor,Programmed Cell Death Protein 1 Inhibitors,Programmed Death-Ligand 1 Inhibitors,Blockade, PD-1-PD-L1,CTLA 4 Inhibitor,CTLA 4 Inhibitors,Checkpoint Blockade, Immune,Checkpoint Blockers, Immune,Checkpoint Inhibition, Immune,Checkpoint Inhibitor, Immune,Checkpoint Inhibitors, Immune,Cytotoxic T Lymphocyte Associated Protein 4 Inhibitor,Cytotoxic T Lymphocyte Associated Protein 4 Inhibitors,Inhibitor, PD-1,PD 1 Inhibitor,PD 1 Inhibitors,PD 1 PD L1 Blockade,PD L1 Inhibitor,PD L1 Inhibitors,Programmed Death Ligand 1 Inhibitors

Related Publications

Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis.
January 2020, Frontiers in neurology,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Case of Immune Checkpoint Inhibitor Induced Myasthenia Gravis.
April 2024, Cureus,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune Checkpoint Inhibitor-Induced Myositis/Myasthenia Gravis Overlap.
November 2023, Cureus,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor.
January 2023, Journal of neurosciences in rural practice,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
August 2021, The American journal of emergency medicine,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single-center case series.
February 2023, Cancer medicine,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis.
October 2020, The Journal of emergency medicine,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.
December 2021, The oncologist,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review.
December 2022, Medicine,
Jason Kuniyoshi, and Ricky Huang, and Horyun Choi, and Monika Bernas, and Witina Techasatian, and Yoshito Nishimura
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.
May 2022, Immunotherapy,
Copied contents to your clipboard!